Epilepsy Monitoring Devices Market

Epilepsy Monitoring Devices Market (Product: Conventional Devices and Wearable Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Epilepsy Monitoring Devices Market Outlook 2031

  • The global epilepsy monitoring devices market was valued at US$ 475.6 Mn in 2021
  • The global market is projected to grow at a CAGR of 4.6% from 2022 to 2031
  • The global epilepsy monitoring devices market is expected to reach more than US$ 737 Mn by the end of 2031

Analysts’ Viewpoint on Epilepsy Monitoring Devices Market Scenario

Advancements in technology; rise in product approvals; and increase in head injuries, brain cancer, and brain infections are expected to drive the global epilepsy monitoring devices market during the forecast period. For instance, the U.S. Food & Drug Administration approved the XCOPRI (cenobamate tablets) to treat partial onset seizures in adults. Existing companies and new entrants are launching new epilepsy monitor devices for children. NeuroPace launched the next-generation RNS system, which is the world’s only brain-computer interface for the treatment of refractory epilepsy. Moreover, genetic factors associated with brain malformations, improvement in health care infrastructure, and increase in investments in healthcare are augmenting the global market.

Epilepsy Monitoring Devices Market

Epilepsy Monitoring Devices Market Introduction

Epilepsy is a disorder of the central nervous system, in which the brain activity becomes abnormal, leading to seizures or periods of unusual behavior, sensations, and loss of awareness. Various conditions such as convulsions and epileptic seizures, including atonic seizures, myoclonic seizures, and tonic-clonic seizures, cause epilepsy. Rise in awareness about panic attack treatment in people is driving the market demand for epilepsy devices. According to the WHO, epilepsy accounts for a considerable proportion of the world’s disease burden; globally, more than 50 million people are affected by this disease. The projected proportion of the general population suffering from active epilepsy at a given time is between 4 and 10 per 1,000 people. Market players in the global epilepsy monitoring devices market are focusing on manufacturing innovative pediatric medical devices to create lucrative growth opportunities.

Request a sample to get extensive insights into the Epilepsy Monitoring Devices Market

Increase in Incidence of Head Injuries, Brain Cancer, and Infections to Drive Demand for Epilepsy Monitors

According to the NCBI, brain tumors are the second most common cause of epilepsy in the older population, behind cerebrovascular illness, and account for between 10% and 30% of all cases of geriatric epilepsy. Patients with brain tumors frequently have epilepsy as one of their symptoms. In 20% to 40% of brain tumor patients, seizures are the first symptom they experience; in 20% to 40% of patients, epileptic seizures are likely to occur at some point over the course of the disease.

According to the International League Against Epilepsy (ILAE), epilepsy and acute symptomatic seizures (which are strongly tied to the date of the initial infection) can both be brought on by diseases in the central nervous system such as meningitis, encephalitis, and neurocysticercosis. Furthermore, according to the American Association of Neurological Surgeons, alcohol or drug misuse and failure to take prescribed anticonvulsant medicine are the primary factors likely to increase the risk of seizures in persons who are prone to them. These factors are expected to drive the global demand for epilepsy monitoring devices during the forecast period.

Genetic Factors Associated with Brain Malformation to Propel Global Market

Malformations of cortical development (MCD) is a significant contributor to developmental impairments, severe epilepsy, and reproductive disadvantage. Genes linked to MCD are mostly involved in neural migration, cell proliferation & specification, and late cortical architecture. These deformities have been linked to abnormalities in the LIS1, DCX, ARX, RELN, VLDLR, ACTB, ACTG1, TUBG1, KIF5C, KIF2A, and CDK5 genes. The International League Against Epilepsy (ILAE) Commission for Classification of Epilepsy, in accordance with the etiologies of epilepsy, classified epilepsies into three categories: genetic, structural/metabolic, and unknown origin. Epilepsy in younger people frequently has a hereditary basis. About 30% of the causes of epilepsy in people are due to genetic factors. Genetic factors can contribute to the ensuing epileptogenesis in ischemic stroke patients.

Request a custom report on Epilepsy Monitoring Devices Market

Growth in Awareness about Epilepsy Monitoring to Augment Demand for Conventional Devices

In terms of product, the global market has been bifurcated into conventional devices and wearable devices. The conventional devices segment dominated the global market in 2021. Increase in awareness initiatives about epilepsy monitoring to reduce cases of SUDEP (Sudden Death due to Epilepsy) is ascribed to the rise in demand for conventional devices.

The wearable devices segment is expected to grow at the fastest CAGR during the forecast period. Wearable epilepsy monitoring equipment such as Empatica’s Embrace not only provides 24-hour surveillance for epilepsy episodes in patients, but can also raise an alarm by sending a message or even making a call immediately to the caregiver in case of an emergency. This feature provides additional support for care providers, leading to an increase in demand for advanced wearables and seizure alert devices such as seizure alarms or seizure monitors.

Significant Government Investment in Healthcare Infrastructure to Bolster Hospitals & Clinics Segment

Based on end-user, the global market has been divided into hospitals & clinics, home care settings, and others. The hospital & clinics segment accounted for major market share in 2021. The segment is anticipated to grow at a high CAGR from 2022 to 2031. Hospitals and clinics are the largest users of EEG monitoring and emergency medical services. The segment is anticipated to offer lucrative opportunities, especially in developing countries. Governments of various countries such as China and India are investing significantly in healthcare infrastructure. Moreover, growth in medical tourism and rise in demand for quality healthcare are likely to augment the hospital & clinics segment during the forecast period.

Regional Outlook of Global Epilepsy Monitoring Devices Market

Europe dominated the global epilepsy monitoring device market in 2021. The market in Europe is expected to grow at a high CAGR from 2022 to 2031 due to the presence of a large geriatric population and increase in healthcare expenditure. According to Epilepsy Action, 600,000 people are living with epilepsy in the U.K., which is nearly equal to people living with autism and four times higher than those living with Parkinson's disease. Furthermore, a study by The Lancet Neurology in 2016 revealed that the prevalence of idiopathic epilepsy in Germany was 429,396.

North America is projected to be the second largest market for epilepsy monitoring tools during the forecast period. This can be ascribed to the high adoption of advanced treatment approaches and favorable reimbursement policies due to rise in patient population that is more susceptible to epilepsy. According to the U.S. Bureau of Labor Statistics, the average disposable income was US$ 3,258 per person per month in the U.S. in 2018, which is about a sixth higher than Canada's average. However, personal disposable income varies quite significantly across different states of the U.S.

Asia Pacific is expected to be the fastest growing region of the global epilepsy monitoring devices market during the forecast period. The market in the region is likely to grow at a high CAGR during the forecast period. Asia Pacific is experiencing increase in adoption of new technologies, rise in healthcare expenditure, and changing dynamics in the healthcare industry. Furthermore, increase in number of patients with epilepsy along with quality improvement in medical education is driving the demand for epilepsy monitoring devices in Asia Pacific.

Analysis of Key Players in Global Epilepsy Monitoring Devices Market

The global epilepsy monitoring devices market is consolidated, with the presence of a small number of large-scale companies. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the key players. Koninklijke Philips N.V, Medtronic plc, Compumedics Limited, Natus Medical Incorporated, Empatica, Inc., PulseGuard International Ltd., and Masimo are the prominent companies operating in the market.

Key Developments in Global Epilepsy Monitoring Devices Market

  • In November 2021, Neurava, one of the startups in biopharmaceuticals, announced it is developing a wearable device to monitor and alert the risk of sudden and unexpected death in epilepsy
  • In September 2020, Neuronostics received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment with anti-epileptic drugs (AEDs)
  • In February 2018, the U.S. Food and Drug Administration approved an mHealth wearable, which detects epileptic seizures and immediately alerts the care team members

Each of these players has been profiled in the epilepsy monitoring devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Epilepsy Monitoring Devices Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 475.6 Mn

Market Forecast Value in 2031

More than US$ 737 Mn

Growth Rate

(CAGR)

4.6%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Conventional Devices
    • Wearable Devices
  • End-user
    • Hospitals & Clinics
    • Home Care Settings
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Koninklijke Philips N.V
  • Medtronic plc
  • Compumedics Limited
  • Natus Medical Incorporated
  • Empatica, Inc.
  • PulseGuard International Ltd.
  • Masimo
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global epilepsy monitoring devices market in 2021?

The global epilepsy monitoring devices market was valued at US$ 475.6 Mn in 2021

How big will be the global epilepsy monitoring devices market in 2031?

The global epilepsy monitoring devices market is projected to reach more than US$ 737 Mn by 2031

What was the CAGR of the global epilepsy monitoring devices market from 2017 to 2021?

The global epilepsy monitoring devices market grew at a CAGR of 3.8% from 2017 to 2021

What will be the CAGR of global epilepsy monitoring devices market during the forecast period (2022–2031)?

The global epilepsy monitoring devices market is anticipated to grow at a CAGR of 4.6% from 2022 to 2031

Which are the prominent trends that affect market growth?

Genetic factors associated with brain malformations and increase in incidence of head injuries, brain cancer, infections, and substance abuse

Which region will account for the major share of the global market during the forecast period?

Europe is expected to account for the major share of the global epilepsy monitoring devices market during the forecast period

Who are the prominent players in the global epilepsy monitoring devices market?

Koninklijke Philips N.V., Medtronic plc, Compumedics Limited, Natus Medical Incorporated, Empatica Inc., PulseGuard International Ltd, and Masimo

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Epilepsy Monitoring Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Epilepsy Monitoring Devices Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Product Details/ Providers/ Technological Advancements

        5.2. Product Details & Pricing Analysis

        5.3. Epidemiology of Epilepsy & Prevalence Data

        5.4. Volume Data for epilepsy devices (2021)

        5.5. Epilepsy Biomarkers

        5.6. Epilepsy Monitoring Devices: Demand/Supply Scenario

    6. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Conventional Devices

            6.3.2. Wearable Devices

        6.4. Market Attractiveness Analysis, by Product

    7. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals & Clinics

            7.3.2. Home Care Settings

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia-Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region/Sub-region

    9. North America Epilepsy Monitoring Devices Market Analysis and Forecast

        9.1. Introduction

        9.2. Market Value Forecast, by Product, 2017–2031

            9.2.1. Conventional Devices

            9.2.2. Wearable Devices

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals & Clinics

            9.3.2. Home Care Settings

            9.3.3. Others

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Epilepsy Monitoring Devices Market Analysis and Forecast

        10.1. Introduction

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Conventional Devices

            10.2.2. Wearable Devices

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals & Clinics

            10.3.2. Home Care Settings

            10.3.3. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. France

            10.4.3. U.K.

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia-Pacific Epilepsy Monitoring Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Conventional Devices

            11.2.2. Wearable Devices

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals & Clinics

            11.3.2. Home Care Settings

            11.3.3. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. Japan

            11.4.2. China

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Epilepsy Monitoring Devices Market Analysis and Forecast

        12.1. Introduction

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Conventional Devices

            12.2.2. Wearable Devices

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals & Clinics

            12.3.2. Home Care Settings

            12.3.3. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Epilepsy Monitoring Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast by Product, 2017–2031

            13.2.1. Conventional Devices

            13.2.2. Wearable Devices

        13.3. Market Value Forecast by End-user, 2017–2031

            13.3.1. Hospitals & Clinics

            13.3.2. Home Care Settings

            13.3.3. Others

        13.4. Market Value Forecast by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. Israel

            13.4.3. South Africa

            13.4.4. Rest of MEA

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Top Players Operating in the Market

        14.2. Market Share/Heat Map Analysis of Product, by Company, 2021

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Koninklijke Philips N.V.

                14.4.1.1. Company Overview

                14.4.1.2. Financial Overview

                14.4.1.3. Product Portfolio

                14.4.1.4. Business Strategies

            14.4.2. Medtronic plc

                14.4.2.1 Company Overview

              14.4.2.2. Financial Overview

              14.4.2.3. Product Portfolio

             14.4.2.4. Business Strategies

            14.4.3. Compumedics Limited

                14.4.3.1. Company Overview

                14.4.3.2. Financial Overview

                14.4.3.3. Product Portfolio

                14.4.3.4. Business Strategies

            14.4.4. Natus Medical Incorporated

                14.4.4.1. Company Overview

                14.4.4.2. Financial Overview

                14.4.4.3. Product Portfolio

                14.4.4.4. Business Strategies

            14.4.5. Empatica, Inc.

                14.4.5.1. Company Overview

                14.4.5.2. Product Portfolio

                14.4.5.3. Business Strategies

            14.4.6. PulseGuard International Ltd.

                14.4.6.1. Company Overview

                14.4.6.2. Product Portfolio

                14.4.6.3. Business Strategies

            14.4.7. Masimo

                14.4.7.1. Company Overview

                14.4.7.2. Financial Overview

                14.4.7.3. Product Portfolio

                14.4.7.4. Business Strategies

    List of Tables

    Table 01: Product Details and Technology

    Table 02: Wrist-worn sensors

    Table 03: Bed monitors

    Table 04: Bed Monitors & Video Monitor 

    Table 05: Epilepsy Prevalence Data

    Table 06: Approximate Volume Data for Epilepsy Devices (2021)

    Table 07: Epilepsy Biomarkers 

    Table 08: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 09: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 10: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 11: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 12: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 13: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 14: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 15: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 16: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 18: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 19: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 20: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 22: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 23: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 24: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 25: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Market Value, by Product (US$ Mn), 2021

    Figure 02: Global Epilepsy Monitoring Devices Market Snapshot

    Figure 03: Global Epilepsy Monitoring Devices Market Share, by End-user, 2021

    Figure 04: Global Epilepsy Monitoring Devices Market Share Analysis, by Region, 2021

    Figure 05: Global Epilepsy Monitoring Devices Market Outlook, by Region

    Figure 06: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 07: Global Epilepsy Monitoring Devices Market Value Share, by Region, 2021

    Figure 08: Global Epilepsy Monitoring Devices Market Value Share, by Product, 2021

    Figure 09: Global Epilepsy Monitoring Devices Market Value Share, by End-user, 2021

    Figure 10: Global Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 11: Global Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 12: Global Epilepsy Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Conventional Devices, 2017–2031

    Figure 13: Global Epilepsy Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wearable Devices, 2017–2031

    Figure 14: Global Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 15: Global Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 16: Global Epilepsy Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2017–2031

    Figure 17: Global Epilepsy Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care Settings, 2017–2031

    Figure 18: Global Epilepsy Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

    Figure 19: Global Epilepsy Monitoring Devices Market Value Share Analysis, by Region, 2021 and 2031

    Figure 20: Global Epilepsy Monitoring Devices Market Attractiveness Analysis, by Region, 2022-2031

    Figure 21: North America Epilepsy Monitoring Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

    Figure 22: North America Epilepsy Monitoring Devices Market Value Share Analysis, by Country, 2021 and 2031

    Figure 23: North America Epilepsy Monitoring Devices Market Attractiveness Analysis, by Country, 2022-2031

    Figure 24: North America Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 25: North America Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 26: North America Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 27: North America Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 28: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

    Figure 29: Europe Epilepsy Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 30: Europe Epilepsy Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

    Figure 31: Europe Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 32: Europe Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 33: Europe Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 34: Europe Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 35: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2021 and 2031

    Figure 36: Asia Pacific Epilepsy Monitoring Devices Market Value Share Analysis, by Country/Sub/region, 2021 and 2031

    Figure 37: Asia Pacific Epilepsy Monitoring Devices Market Attractiveness Analysis, by Country, 2022-2031

    Figure 38: Asia Pacific Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 39: Asia Pacific Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 40: Asia Pacific Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 41: Asia Pacific Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 42: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2021 and 2031

    Figure 43: Latin America Epilepsy Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 44: Latin America Epilepsy Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 45: Latin America Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 46: Latin America Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 47: Latin America Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 48: Latin America Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 49: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

    Figure 50: MEA Epilepsy Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 51: MEA Epilepsy Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 52: MEA Epilepsy Monitoring Devices Market Value Share Analysis, by Product, 2021 and 2031

    Figure 53: MEA Epilepsy Monitoring Devices Market Attractiveness Analysis, by Product, 2022-2031

    Figure 54: MEA Epilepsy Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 55: MEA Epilepsy Monitoring Devices Market Attractiveness Analysis, by End-user, 2022-2031

Copyright © Transparency Market Research, Inc. All Rights reserved